Population genetics of IFITM3 in Portugal and Central Africa reveals a potential modifier of influenza severity

• Autor(a) principal: David, S
• Data de Publicação: 2017
• Outros Autores: Correia, V, Antunes, L, Faria, R, Ferrão, J, Faustino, P, Nunes, B, Maltez, F, Lavinha, J, Rebelo de Andrade, H
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• Texto Completo: http://hdl.handle.net/10400.18/4825
• topic: IFITM3 gene; influenza Virus; Population Genetics; Portugal; Central Africa; Agentes Microbianos e Ambiente; Infecções Respiratórias; Determinantes da Saúde e da Doença

Influenza epidemics are a serious global public health and economic problem. The IFITM3 allele (rs12252-C) was suggested as a strong population-based genetic risk factor for severe influenza virus infection by A(H1N1)pdm09. We analyzed the population genetics of IFITM3 variants in Portuguese general population (n=200) and Central Africans (largely Angolan) (n=148) as well as its association to influenza severity in Portuguese patients (n=41). Seven SNPs, within the 352bp IFITM3 amplicon around rs12252, were identified. SNP distributions in the Portuguese appeared at an intermediate level between the Africans and other Europeans. According to HapMap rs34481144 belongs to the same linkage disequilibrium (LD) block as rs12252, and is in strong LD with rs6421983. A negative association with severe relative to mild disease was observed for allele rs34481144-A, indicating a protective effect under the dominant model. Moreover, haplotype Hap4 with rs34481144-A, not including rs12252-C, was significantly associated to mild influenza. Conversely, although with borderline significance, haplotype Hap1 with rs34481144-G, not including rs12252-C, was associated to severe disease. Moreover, in comparison to the general Portuguese population, statistical significant differences in the frequencies of the protective allele rs34481144-A in the severe disease group, the deleterious Hap1 in the mild disease group and the protective Hap4 in the severe disease group, were observed. The population attributable risk (PAR) for the targeted rs34481144 allele or genotype was of 55.91% and 64.44% in the general population and the mildly infected individuals, respectively. Implication of these variants in disease phenotype needs further validation, namely through functional analysis as is discussed.